| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0733-8619(18)30882-X |
| P698 | PubMed publication ID | 2837633 |
| P2093 | author name string | Arana GW | |
| Mossman D | |||
| P2860 | cites work | Singledose dexamethasone suppression test for Cushing's Syndrome | Q24672384 |
| Plasma desoxycorticosterone levels in man with simultaneous measurement of aldosterone, corticosterone, cortisol and 11-deoxycortisol | Q28239991 | ||
| The meaning and use of the area under a receiver operating characteristic (ROC) curve | Q29547182 | ||
| The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review | Q34161551 | ||
| The predictive power of diagnostic tests and the effect of prevalence of illness | Q34271408 | ||
| A method of comparing the areas under receiver operating characteristic curves derived from the same cases | Q34272510 | ||
| Psychoneuroendocrinology of affective disorder: an overview | Q35907314 | ||
| Evaluation of receiver operating characteristic curve data in terms of information theory, with applications in radiography | Q36527491 | ||
| Cushing's syndrome: A review of diagnostic tests | Q38007987 | ||
| Can antidepressants cause mania and worsen the course of affective illness? | Q39677054 | ||
| A review of psychoendocrine research on the pituitary-adrenal cortical system | Q39890690 | ||
| Differences in Corticosterone and Dexamethasone Binding to Rat Brain and Pituitary1 | Q39920822 | ||
| Corticosteroid Inhibition of ACTH Secretion* | Q40141045 | ||
| Cortisol Determination and the Dexamethasone Suppression Test | Q40147350 | ||
| Daily Rhythms in Adrenal Responsiveness to Adrenocorticotropin Are Determined Primarily by the Time of Feeding in the Rat* | Q40230007 | ||
| “Normal Suppression” to Dexamethasone in Cushing's Disease: An Expression of Decreased Metabolic Clearance for Dexamethasone | Q40301504 | ||
| The dexamethasone suppression test for melancholia | Q40342019 | ||
| Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility | Q41446274 | ||
| Psychotropic drug withdrawal and the dexamethasone suppression test | Q44447470 | ||
| Bioavailability of dexamethasone; II. Dexamethasone phosphate | Q45030087 | ||
| Influence of weight loss on the dexamethasone suppression test | Q47254436 | ||
| Radioimmunoassay of human plasma corticosterone: Method, measurement of episodic secretion and adrenal suppression and stimulation | Q47828810 | ||
| Plasma corticosterone and cortisol following dexamethasone in psychiatric patients | Q48551963 | ||
| Psychiatric implications of basic and clinical studies with corticotropin-releasing factor | Q48679681 | ||
| Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression | Q48903699 | ||
| 17-Ketosteroid excretion in a case of manic-depressive psychosis. | Q51341487 | ||
| Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. | Q52090893 | ||
| Comparison of solid-phase radioimmunoassay and competitive protein binding method for postdexamethasone cortisol levels in psychiatric patients. | Q52433610 | ||
| Dexamethasone suppression test and serum prolactin in dementia disorders. | Q53309276 | ||
| A radioimmunoassay procedure for dexamethasone: plasma and urine levels in man | Q53925674 | ||
| Characterization of the normal temporal pattern of plasma corticosteroid levels. | Q54114347 | ||
| Plasma acth and cortisol levels in depressed patients: Relation to dexamethasone suppression test | Q54447522 | ||
| Cortisol, 11-deoxycortisol, and ACTH concentrations after dexamethasone in depressed patients and healthy volunteers. | Q54484888 | ||
| Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. | Q54518999 | ||
| Cortisol secretion and dexamethasone response in depression | Q54531331 | ||
| Aging and cortisol resistance to suppression by dexamethasone: a positive correlation | Q57318005 | ||
| Dexamethasone suppression test in a pluri-diagnostic approach: its relationship to psychopathological and clinical variables | Q57739755 | ||
| Melancholic subtyping: a qualitative or quantitative distinction? | Q60447157 | ||
| Circadian Analysis of Plasma Cortisol Levels Before and After Dexamethasone Administration in Depressed Patients | Q60639003 | ||
| Bioavailability of oral dexamethasone | Q66897847 | ||
| Quantitation of dexamethasone in biological fluids using high-performance liquid chromatography | Q67462701 | ||
| Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects | Q68627349 | ||
| Hydrocortisone suppression test for Cushing syndrome. Therapy with anticonvulsants | Q68702966 | ||
| A plasma dexamethasone radioimmunoassay | Q69697333 | ||
| The dexamethasone suppression test as a monitor of clinical recovery | Q69711225 | ||
| Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders | Q70026999 | ||
| Plasma cortisol determination for the dexamethasone suppression test. Comparison of competitive protein-binding and commercial radioimmunoassay methods | Q70083095 | ||
| Plasma ACTH levels in primary depression: relationship to the 24-hour dexamethasone suppression test | Q70161010 | ||
| Pretreatment DST and Hypothalamic-Pituitary-Adrenocortical Function in Depressed Patients and Comparison Groups | Q70330394 | ||
| Simultaneous determination of corticosterone, hydrocortisone, and dexamethasone in dog plasma using high performance liquid chromatography | Q70456048 | ||
| Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia | Q70502416 | ||
| The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups | Q70538315 | ||
| Dexamethasone suppression test in female patients with endogenous depression: determinations of plasma corticosterone, 11-deoxycorticosterone, 11-deoxycortisol, cortisol and cortisone | Q70582526 | ||
| Validation of four definitions of melancholia by the dexamethasone suppression test | Q70636360 | ||
| The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry | Q70640399 | ||
| Clinical use of the DST in a psychogeriatric population | Q70640403 | ||
| Response to dexamethasone and subtype of depression | Q70650467 | ||
| [Dexamethasone suppression test: a biologic marker of endogenous depression?] | Q70671976 | ||
| Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients | Q70970463 | ||
| Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification | Q71258107 | ||
| Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression | Q71302856 | ||
| The dexamethasone suppression test in patients with presenile and senile dementia of the Alzheimer's type | Q71359380 | ||
| Age and the dexamethasone suppression test in depression | Q71380677 | ||
| Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia | Q71405712 | ||
| A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility | Q71465909 | ||
| Comparison of absorption, disposal, and activity of soluble and repository corticosteroid esters | Q72414402 | ||
| Simplified dexamethasone suppression test | Q72527688 | ||
| The Site of Inhibitory Action of a Natural (Corticosterone) and Synthetic Steroid (Dexamethasone) in the Hypothalamus-Pituitary-Adrenal Axis | Q72888447 | ||
| In Vivo Corticotropin-Releasing Factor-Induced Secretion of Adrenocorticotropin, β-Endorphin, and Corticosterone* | Q72917576 | ||
| The diurnal variation of plasma cortisol levels in depression | Q72922350 | ||
| Plasma cortisol in depressive illness | Q79487674 | ||
| P433 | issue | 1 | |
| P921 | main subject | dexamethasone | Q422252 |
| P304 | page(s) | 21-39 | |
| P577 | publication date | 1988-02-01 | |
| P1433 | published in | Neurologic Clinics | Q15756619 |
| P1476 | title | The dexamethasone suppression test and depression. Approaches to the use of a laboratory test in psychiatry | |
| P478 | volume | 6 |
| Q48374918 | Assessment and treatment of depression in the cancer patient |
| Q48766803 | Brain corticotropin-releasing factor immunoreactivity and receptors in five inbred rat strains: relationship to forced swimming behaviour |
| Q35236725 | Changes in the immune system in depression and dementia: causal or coincidental effects? |
| Q56767394 | Cluster analytic validation of the DSM melancholic depression. The threshold model: integration of quantitative and qualitative distinctions between unipolar depressive subtypes |
| Q33857662 | Pathways linking late-life depression to persistent cognitive impairment and dementia. |
| Q47819047 | Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis |
Search more.